Blog

• 
• 
• 
• 

Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. But in early studies, breast cancer has proven to be largely resistant to immunotherapies, which are effective in only about 5 to 10 percent of patients whose tumors have spread or metastasized.

Two engineering professors have been named fellows of The Optical Society (OSA), a leading international association for optics and photonics.

Along with the blast of arctic air that put much of the U.S. into a deep freeze at the start of 2018, the new year also ushered in one of the most widespread—and deadly—flu seasons in recent memory. Dr. James Crowe, director of the Vanderbilt Vaccine Center, hopes to solve this problem by eliminating the guesswork altogether.

In two years, the world may see a revolutionary solution to the century-old approach of allocating bands for specific use on the radio frequency spectrum. Vanderbilt may help solve the problem.

Phaeodactylum tricornutum is a microscopic, single-celled algae with outsized potential.

A new device that can image diseases of the retina more quickly will soon be tested during ophthalmic surgeries with Vanderbilt Eye Institute collaborators.

The prototype was designed by a Vanderbilt engineering undergraduate, who is first author on a paper about the work she will present today at the largest photonics conference in the world.

Researchers at Vanderbilt University have discovered how insulin crosses the capillary endothelium to exit blood vessels and stimulate skeletal muscle cells — a major finding that may lead to new ways to reverse insulin resistance, a hallmark of type 2 diabetes.

If you’ve kept up with science-related news lately, then you’ve probably heard about CRISPR-Cas9, the latest and greatest new tool for gene editing.

Clostridium difficile (C. difficile) infection is the leading cause of hospital-acquired diarrhea, causing nearly a half million infections in the United States each year. Recurrence after treatment with antibiotics is common and new therapies are needed.

A six-member group of biomedical scientists from Europe and the United States, including Eric Delpire, PhD, MS, professor of Anesthesiology, has been awarded a $6 million grant to study the role of dietary potassium in hypertension.

The five-year grant was awarded by the Paris-based Fondation LeDucq as part of its Transatlantic Networks of Excellence Program.